Insulin Resistance presentations about Insulin Resistance EB with interest for Insulin Resistance Validating Insulin Resistance content Free registration form / enregistrement gratuit
1
2
   - July 4, 2008
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.

CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
  Biography  

Dr. Julio Rosenstock

Julio Rosenstock, MD
Clinical Professor of Medicine
University of Texas Southwestern Medical School
Dallas, Texas


Julio Rosenstock, MD, a board certified specialist in internal medicine and endocrinology and metabolism, is a Clinical Professor of Medicine in the Department of Internal Medicine at the University of Texas Southwestern Medical School in Dallas. He is also in endocrine practice and clinical research at the Dallas Diabetes and Endocrine Center. Dr. Rosenstock earned his medical degree at the University of Costa Rica School of Medicine. He completed a fellowship in endocrinology and diabetes at the Royal Postgraduate Medical School and Hammersmith Hospital in London and the University of Texas Southwestern Medical Center in Dallas.

Active in clinical research, Dr. Rosenstock has published more than 70 articles and 60 abstracts and contributed to eight book chapters on various topics in the field of diabetes, including hypertension in diabetes; diabetic neuropathy; nephropathy and glycemic control; blood glucose and genetic susceptibility; monotherapy and combination therapy in the treatment of diabetes; insulin therapy; nocturnal hypoglycemia; and management of diabetes in the elderly. His clinical and research activities have focused on intensive diabetes management strategies and novel therapies to improve glycemic control to prevent and retard diabetes complications. His work has appeared in such journals as Diabetes Care; JAMA; Lancet; Annals of Internal Medicine; Diabetes, Obesity, and Metabolism; and The American Journal of Medicine. Dr. Rosenstock served as a member of the editorial board of Clinical Diabetes and Endocrine Practice. He currently serves on the editorial board of Practical Diabetology, The Journal of the HispanoAmerican Biomedical Association, and Cardiovascular Diabetology.

Dr. Rosenstock is a member of the American College of Physicians, American Diabetes Association, Endocrine Society, American Association of Clinical Endocrinologists, American Federation for Clinical Research, and the European Association for the Study of Diabetes.




 
  List of presentations from this healthcare provider available on CMEonDiabetes :

Based on these mechanisms, are beta-cells a therapeutic target for slowing...
english - 2004-06-04 - 25 minutes
What is the evidence for combination therapy with a TZD added to metformin...
english - 2004-06-04 - 21 minutes
What is the increasing evidence that supports TZDs and their extraglycemic...
english - 2004-06-04 - 10 minutes
Are there any outcome measures that suggest a favorable vascular effect...
english - 2004-06-04 - 15 minutes
Dr. Rosenstock Summary
english - 2004-06-04 - 6 minutes
  Login
  Username :
  Password :
   
  Lost your password?


  Social
  Let others know about this biography.

 Del.icio.us
 Digg!

  Search our website
  Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes.
 



ezCME: HIV - Insulin Resistance - C-Reactive Protein (CRP) - ADHD - Sleep Disorder - Prostate Health - Hemophilia - Transplantation

CMEonDiabetes is owned by E-MedHosting.com.


Copyright © 2002-2008 E-MedHosting.com. All rights reserved.  Disclaimer

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.